Dymon Asia Capital (Singapore)’s Sanofi SNY Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42M	Buy	+33,400	New	+$1.49M	0.06%	150

Other funds holding SNY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

TAM

Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s SNY Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) opened a new position in Sanofi (SNY) in Q2 2026: 33,400 shares worth $1.42M. The stake represents 0.06% of the portfolio and ranks #150 among its holdings.

319 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Dymon Asia Capital (Singapore) held 33,400 shares of Sanofi worth $1.42M as of Q2 2026.
Sanofi was a new Dymon Asia Capital (Singapore) position in Q2 2026.
Sanofi made up 0.06% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #150 holding.
319 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.